GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds Bookmark CommentsGo to comments Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who dont use the medications, researchers said Monday
[DOI] [PubMed] [Google Scholar] 24.Houston D.K., Nicklas B.J., Ding J., Harris T.B., Tylavsky F.A., Newman A.B., et al
I honestly couldnt tell you the difference between an iced latte from Starbucks and this drink. She also appreciated the smooth texture and notes, I liked that it didnt taste like a protein drink, which matters if typical shakes feel too thick, too sweet, or too chalky, all of which can be common turnoffs
Cutaneous manifestations in disorders of hepatobiliary system
doi:10.1146/annurev.arplant.50.1.47
Niessl J, Sekine T, Lange J, Konya V, Forkel M, Maric J, et al